European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
28 11 2022
Historique:
received: 19 04 2022
accepted: 31 08 2022
pubmed: 8 10 2022
medline: 1 12 2022
entrez: 7 10 2022
Statut: ppublish

Résumé

To describe the susceptibility of Escherichia coli to medically important antibiotics, collected over four periods (2004-2006, 2008-2009, 2013-2014, 2017-2018), from food-producing animals at slaughter. Intestinal contents from cattle, pigs and broilers were randomly sampled (5-6 countries/host; ≥4 abattoirs/country; one sample/animal/farm) for isolation of Escherichia coli; antimicrobial susceptibilities were centrally determined by CLSI agar dilution. Clinical breakpoints (CLSI) and epidemiological cut-off values (EUCAST) were applied for data interpretation. In total, 10 613 E. coli strains were recovered. In broilers, resistance percentages were the lowest (P ≤ 0.01) in the latest time period. A significant decrease in MDR over time was also observed for broilers and a tendency for a decrease for pigs. Resistance to meropenem and tigecycline was absent, and resistance to azithromycin was 0.2%-2.0%. Also, low resistance to third-generation cephalosporins (1.1%-7.4%) was detected in broilers. Resistance to colistin varied between 0.1%-4.8%. E. coli from broilers showed high resistance to ciprofloxacin (7.3%-23.3%), whereas for cattle and pigs this was 0.2%-2.5%. Low/moderate resistance to chloramphenicol (9.3%-21.3%) and gentamicin (0.9%-7.0%) was observed in pigs and broilers. The highest resistance was noted for ampicillin (32.7%-65.3%), tetracycline (41.3%-67.5%), trimethoprim (32.0%-35.7%) and trimethoprim/sulfamethoxazole (27.5%-49.7%) from pigs and broilers, with marked country differences. MDR peaked in pigs and broilers with 24 and 26 phenotypes, with 21.9%-26.2% and 18.7%-34.1% resistance, respectively. In this pan-EU survey antibiotic susceptibility of commensal E. coli varied largely between antibiotics, animal species and countries. Resistance to critically important antibiotics for human medicine was absent or low, except for ciprofloxacin in broilers and ampicillin in pigs and broilers.

Identifiants

pubmed: 36203261
pii: 6750681
doi: 10.1093/jac/dkac318
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ampicillin 7C782967RD
Ciprofloxacin 5E8K9I0O4U
Trimethoprim, Sulfamethoxazole Drug Combination 8064-90-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3301-3311

Investigateurs

Marion Ocak (M)
Pascal Butty (P)
Rebecca Klee (R)
Guido Schiffer (G)
Clelia Stevenin (C)
Pieter-Jan Serreyn (PJ)
Robin Temmerman (R)

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Anno De Jong (A)

EASSA Study Group, c/o CEESA, 168, Av. de Tervueren, Brussels, Belgium.

Farid El Garch (F)

EASSA Study Group, c/o CEESA, 168, Av. de Tervueren, Brussels, Belgium.
Vetoquinol S.A., Lure, France.

Didier Hocquet (D)

Infection Control Unit, University Hospital of Besançon, CHU Besançon, France.
UMR 6249, Chrono-Environnement, Université de Bourgogne Franche-Comté, Besançon, France.

Ellen Prenger-Berninghoff (E)

Institute of Hygiene and Infectious Diseases of Animals, Department of Veterinary Medicine, Justus Liebig University Giessen, Giessen, Germany.

Jeroen Dewulf (J)

Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.

Lourdes Migura-Garcia (L)

IRTA-UAB Mixed Research Unit in Animal Health, Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain.
IRTA, Animal Health Programme, CReSA, OIE Collaborating Centre, Campus de la Universitat Autònoma de Barcelona, Spain.

Agnès Perrin-Guyomard (A)

Anses, Fougères Laboratory, France.

Kees T Veldman (KT)

Wageningen Bioveterinary Research, Lelystad, The Netherlands.

Szilard Janosi (S)

Laboratory of Bacteriology, National Food Chain Safety Office, Budapest, Hungary.

Magdalena Skarzynska (M)

Department of Microbiology, National Veterinary Research Institute, Puławy, Poland.

Shabbir Simjee (S)

EASSA Study Group, c/o CEESA, 168, Av. de Tervueren, Brussels, Belgium.
Elanco Animal health, Basingstoke, UK.

Hilde Moyaert (H)

EASSA Study Group, c/o CEESA, 168, Av. de Tervueren, Brussels, Belgium.
Zoetis, Zaventem, Belgium.

Markus Rose (M)

EASSA Study Group, c/o CEESA, 168, Av. de Tervueren, Brussels, Belgium.
MSD Animal Health Innovation GmbH, Schwabenheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH